L Oróstica1, I Astorga1, F Plaza-Parrochia1, C Vera1, V García2, R Carvajal3, F Gabler4, C Romero1,3, M Vega1,3. 1. Laboratory of Endocrinology and Reproductive Biology, Clinical Hospital, University of Chile, Santiago, Chile. 2. Faculty of Health Sciences, University of Antofagasta, Antofagasta, Chile. 3. Department of Obstetrics and Gynecology, Faculty of Medicine, Clinical Hospital, University of Chile, Santiago, Chile. 4. Department of Pathology, Faculty of Medicine, University of Chile, San Borja Arriarán Clinical Hospital, Santiago, Chile.
Abstract
BACKGROUND/ OBJECTIVES: A high percentage of women having polycystic ovarian syndrome (PCOS) exhibit hyperinsulinemia and obesity. Transforming necrosis factor-α (TNF-α) is an adipokine that increases in obesity and negatively affects insulin action in several tissues, including the endometrium. In fact, it has been reported that insulin signaling is altered in the endometrium of PCOS women, affecting its reproductive function. The aim of this study was to determine the proinflammatory environment and TNF-α signaling in endometrium from obese women with PCOS, and also to evaluate the effect of TNF-α on endometrial cell energy homeostasis. METHODS: Serum and endometrial tissues were obtained from four study groups: normal-weight, normal-weight-PCOS, obese and obese-PCOS (hyperandrogenemia/hyperinsulinemia) (n=7 per group). Serum TNF-α level was assayed by enzyme-linked immunosorbent assay (ELISA); endometrial TNF-α level and its receptors (TNFR1/TNFR2) as well as nuclear factor (NF)-κB content were determined by immunohistochemistry. Finally, we evaluated TNF-α effect on glucose uptake in cultured human endometrial stromal cells (T-HESC) treated or not with testosterone/insulin resembling partially the PCOS condition. RESULTS: TNF-α plasma levels were similar between groups, whereas cytokine levels and macrophage number increased in endometrium from obese-PCOS women (P<0.001). Both receptor types were higher in obese vs normal-weight women, particularly TNFR2 content in the obese-PCOS group (P<0.001). Furthermore, an increased NF-κB nuclear content in endometrium from obese-PCOS was observed (P<0.001). Finally, TNF-α treatment of T-HESC cultures exhibited a decrease of glucose uptake (P<0.05), although similar to cells treated with testosterone or testosterone/insulin/TNF-α. CONCLUSIONS: These results suggest that the PCOS condition induces an inflammatory state exacerbated when obesity is present, where a higher TNF-α signaling is observed, all of which could affect glucose uptake in the tissue and may cause fertility failures in these women.
BACKGROUND/ OBJECTIVES: A high percentage of women having polycystic ovarian syndrome (PCOS) exhibit hyperinsulinemia and obesity. Transforming necrosis factor-α (TNF-α) is an adipokine that increases in obesity and negatively affects insulin action in several tissues, including the endometrium. In fact, it has been reported that insulin signaling is altered in the endometrium of PCOSwomen, affecting its reproductive function. The aim of this study was to determine the proinflammatory environment and TNF-α signaling in endometrium from obesewomen with PCOS, and also to evaluate the effect of TNF-α on endometrial cell energy homeostasis. METHODS: Serum and endometrial tissues were obtained from four study groups: normal-weight, normal-weight-PCOS, obese and obese-PCOS (hyperandrogenemia/hyperinsulinemia) (n=7 per group). Serum TNF-α level was assayed by enzyme-linked immunosorbent assay (ELISA); endometrial TNF-α level and its receptors (TNFR1/TNFR2) as well as nuclear factor (NF)-κB content were determined by immunohistochemistry. Finally, we evaluated TNF-α effect on glucose uptake in cultured human endometrial stromal cells (T-HESC) treated or not with testosterone/insulin resembling partially the PCOS condition. RESULTS: TNF-α plasma levels were similar between groups, whereas cytokine levels and macrophage number increased in endometrium from obese-PCOSwomen (P<0.001). Both receptor types were higher in obese vs normal-weight women, particularly TNFR2 content in the obese-PCOS group (P<0.001). Furthermore, an increased NF-κB nuclear content in endometrium from obese-PCOS was observed (P<0.001). Finally, TNF-α treatment of T-HESC cultures exhibited a decrease of glucose uptake (P<0.05), although similar to cells treated with testosterone or testosterone/insulin/TNF-α. CONCLUSIONS: These results suggest that the PCOS condition induces an inflammatory state exacerbated when obesity is present, where a higher TNF-α signaling is observed, all of which could affect glucose uptake in the tissue and may cause fertility failures in these women.
Authors: B Falini; L Flenghi; S Pileri; M Gambacorta; B Bigerna; H Durkop; F Eitelbach; J Thiele; R Pacini; A Cavaliere Journal: Am J Pathol Date: 1993-05 Impact factor: 4.307
Authors: Troy A Markel; Paul R Crisostomo; Meijing Wang; Christine M Herring; Daniel R Meldrum Journal: Am J Physiol Gastrointest Liver Physiol Date: 2007-07-19 Impact factor: 4.052
Authors: Mohamed A Abedel-Majed; Sarah M Romereim; John S Davis; Andrea S Cupp Journal: Front Endocrinol (Lausanne) Date: 2019-11-29 Impact factor: 6.055
Authors: R Paravati; N De Mello; E K Onyido; L W Francis; K Brüsehafer; K Younas; S Spencer-Harty; R S Conlan; D Gonzalez; Lavinia Margarit Journal: J Mol Med (Berl) Date: 2020-10-13 Impact factor: 4.599
Authors: Megan Chambers; April Rees; James G Cronin; Manju Nair; Nicholas Jones; Catherine A Thornton Journal: Front Immunol Date: 2021-01-14 Impact factor: 7.561